Vienna Likely to Extend Oil Production Cuts

Saudi Energy Minister alongside his Cuban and Russian counterparts at an Organization of the Petroleum Exporting Countries (OPEC) presser. PHOTO: AFP
Saudi Energy Minister alongside his Cuban and Russian counterparts at an Organization of the Petroleum Exporting Countries (OPEC) presser. PHOTO: AFP
TT

Vienna Likely to Extend Oil Production Cuts

Saudi Energy Minister alongside his Cuban and Russian counterparts at an Organization of the Petroleum Exporting Countries (OPEC) presser. PHOTO: AFP
Saudi Energy Minister alongside his Cuban and Russian counterparts at an Organization of the Petroleum Exporting Countries (OPEC) presser. PHOTO: AFP

OPEC and Russia seem to be moving toward extending the oil production cut agreement until the end of 2018, but have hinted reconsidering the agreement when they meet again in June.

In response, oil prices had edged up on Thursday, ahead of OPEC’s meeting during which producers are expected to extend a supply-cut deal that came into effect in January with the goal of tightening supplies and propping up prices.

A committee of OPEC energy ministers and independent producers, including Saudi Arabia and Russia, recommended that OPEC and non-OPEC allies extend oil production cuts by nine months at a meeting in Vienna on Tuesday.

"The (oil) market has not yet achieved full stability, and there is a need for further action beyond April 1," Russian Energy Minister Alexander Novak said.

“Everyone (in the committee) recommends extending the agreement.”

Novak met his Saudi counterpart Khalid al-Falih on Wednesday, one day before a full OPEC meeting in Vienna to discuss oil prices, the Russian energy ministry said in a statement on Twitter.

With oil prices above $60 a barrel, Russia has questioned the effectiveness of extending the current production cuts of 1.8 million barrels per day until the end of next year-- such a move could lead to an increase in US production.

Six ministers from oil-producing countries within and outside OPEC held a meeting to decide on recommendations.

OPEC is scheduled to organize an open session, including media, at (0900 GMT) in Vienna on Thursday, before going into a closed session at noon, according to a tentative program on OPEC’s website. Non-OPEC ministers are set to join at 3 p.m., followed by a joint press conference after the meeting.

The production cuts have been in place since the start of 2017 and helped halve an excess of global oil stocks although those remain at 140 million barrels above the five-year average, according to OPEC.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.